Showing results (651-660 of 692) with videos related to

Sort By:
Pageof 70
Public Health Reports (Washington, D.C. : 1974)|February 9, 2022
Acceptance of Saliva-Based Specimen Collection for SARS-CoV-2 Testing Among K-12 Students, Teachers, and StaffHeather P McLaughlin, Mary Claire Worrell, Sara Malone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2023
Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment ProgramP McLaughlin, A J Grillo-López, B K Link, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment programP McLaughlin, A J Grillo-López, B K Link, et al.
Biology Letters|March 2, 2018
Local extinction of the Asian tiger mosquito (Aedes albopictus) following rat eradication on Palmyra AtollKevin D Lafferty, John P McLaughlin, Daniel S Gruner, et al.
Molecules (Basel, Switzerland)|July 12, 2025
Dual Opioid-Neuropeptide FF Small Molecule Ligands Demonstrate Analgesia with Reduced Tolerance LiabilitiesMarco Mottinelli, V Blair Journigan, Samuel Obeng, et al.
Frontiers in Microbiology|January 23, 2025
Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance-India, 2018-2020Sembulingam Tamilzhalagan, Evanslin Santus Justin, Ashok Selvaraj, et al.
Emerging Infectious Diseases|January 22, 2020
Rapid Nanopore Whole-Genome Sequencing for Anthrax Emergency PreparednessHeather P McLaughlin, Julia V Bugrysheva, Andrew B Conley, et al.
Nature|July 3, 2024
A µ-opioid receptor modulator that works cooperatively with naloxoneEvan S O'Brien, Vipin Ashok Rangari, Amal El Daibani, et al.
Pageof 70